| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.1 |